449 related articles for article (PubMed ID: 24642143)
1. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
2. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
3. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.
Pennington LF; Gasser P; Brigger D; Guntern P; Eggel A; Jardetzky TS
J Allergy Clin Immunol; 2021 Oct; 148(4):1049-1060. PubMed ID: 33991582
[TBL] [Abstract][Full Text] [Related]
5. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Lewkowich I; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Jun; 131(6):1555-64. PubMed ID: 23632296
[TBL] [Abstract][Full Text] [Related]
6. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
Gomez G
Front Immunol; 2019; 10():175. PubMed ID: 30792720
[TBL] [Abstract][Full Text] [Related]
7. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
[TBL] [Abstract][Full Text] [Related]
8. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
[TBL] [Abstract][Full Text] [Related]
9. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
10. Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.
Dispenza MC; Bochner BS; MacGlashan DW
Front Immunol; 2020; 11():614402. PubMed ID: 33391286
[TBL] [Abstract][Full Text] [Related]
11. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab.
Gasser P; Tarchevskaya SS; Guntern P; Brigger D; Ruppli R; Zbären N; Kleinboelting S; Heusser C; Jardetzky TS; Eggel A
Nat Commun; 2020 Jan; 11(1):165. PubMed ID: 31913280
[TBL] [Abstract][Full Text] [Related]
12. An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis.
Zhou JS; Sandomenico A; Severino V; Burton OT; Darling A; Oettgen HC; Ruvo M
Mol Biosyst; 2013 Nov; 9(11):2853-9. PubMed ID: 24056872
[TBL] [Abstract][Full Text] [Related]
13. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
15. The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses.
Moñino-Romero S; Erkert L; Schmidthaler K; Diesner SC; Sallis BF; Pennington L; Jardetzky T; Oettgen HC; Bohle B; Fiebiger E; Szépfalusi Z
Allergy; 2019 Feb; 74(2):236-245. PubMed ID: 30030936
[TBL] [Abstract][Full Text] [Related]
16. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
Front Immunol; 2019; 10():1020. PubMed ID: 31156621
[TBL] [Abstract][Full Text] [Related]
17. Rat monoclonal anti-murine IgE antibody removes IgE molecules already bound to mast cells or basophilic leukemia cells, resulting in the inhibition of systemic anaphylaxis and passive cutaneous anaphylaxis.
Miyajima H; Watanabe N; Ovary Z; Okumura K; Hirano T
Int Arch Allergy Immunol; 2002 May; 128(1):24-32. PubMed ID: 12037398
[TBL] [Abstract][Full Text] [Related]
18. IgE, mast cells, basophils, and eosinophils.
Stone KD; Prussin C; Metcalfe DD
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S73-80. PubMed ID: 20176269
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock.
Nakamura Y; Nakano N; Ishimaru K; Ando N; Katoh R; Suzuki-Inoue K; Koyanagki S; Ogawa H; Okumura K; Shibata S; Nakao A
J Allergy Clin Immunol; 2016 Apr; 137(4):1226-1235. PubMed ID: 26559325
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
